These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 435130)

  • 1. Plasma administration to defibrinogenated dogs during extracorporeal circulation.
    Berglin E; Hansson HA; William-Olsson G
    Artif Organs; 1979 Feb; 3(1):80-5. PubMed ID: 435130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic clot formation at anastomosis of synthetic venous graft in defibrinogenated dogs: a scanning electron microscopic study.
    Ishimaru S; Berglin E; Hansson HA; Teger-Nilsson AC; William-Olsson G
    Thromb Haemost; 1981 Jun; 45(3):276-81. PubMed ID: 7025342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation with defibrase during prolonged extracorporeal circulation in the dog.
    Berglin E; Svalander ; Teger-Nilsson A-C ; William-Olsson G
    Scand J Thorac Cardiovasc Surg; 1976; 10(3):225-30. PubMed ID: 1006222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defibrinogenation as an alternative to heparinization during prolonged extracorporeal circulation in the dog.
    Berglin E; Hansson HA; Teger-Nilsson AC; William-Olsson G
    Thromb Res; 1976 Jul; 9(1):81-93. PubMed ID: 960064
    [No Abstract]   [Full Text] [Related]  

  • 5. Administration of plasma to dogs defibrinogenated with defibrase.
    Berglin E; Svalander C; Teger-Nilsson AC; William-Olsson G
    Thromb Res; 1978 Nov; 13(5):785-98. PubMed ID: 741451
    [No Abstract]   [Full Text] [Related]  

  • 6. Pseudointima in expanded polytetrafluoroethylene graft implanted in the inferior vena cava of normal and defibrinogenated dogs.
    Ishimaru S; William-Olsson EB; Hansson HA; Teger-Nilsson AC; William-Olsson G
    Artif Organs; 1981 May; 5(2):143-51. PubMed ID: 7271527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience of extensive vascular surgery on defibrase-defibrinogenated patients.
    Olsson P; Blombäck M; Egberg N; Ekeström S
    Thromb Res; 1976 Sep; 9(3):277-87. PubMed ID: 982350
    [No Abstract]   [Full Text] [Related]  

  • 8. On platelet fibrinogen in plasma defibrinogenated dogs and in uremic patients before and after hemodialysis.
    Johnsson H
    Thromb Res; 1975 Jul; 7(1):161-74. PubMed ID: 1154334
    [No Abstract]   [Full Text] [Related]  

  • 9. Modification of batroxobin with activated polyethylene glycol: reduction of binding ability towards anti-batroxobin antibody and retention of defibrinogenation activity in circulation of preimmunized dogs.
    Nishimura H; Takahashi K; Sakurai K; Fujinuma K; Imamura Y; Ooba M; Inada Y
    Life Sci; 1983 Oct; 33(15):1467-73. PubMed ID: 6353117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacodynamics and pharmacokinetics of batroxobin in Beagle dog].
    Zheng ZH; Zhu XX; Gan H; Gu RL; Wu ZN; Meng ZY; Dou GF
    Yao Xue Xue Bao; 2013 Aug; 48(8):1307-11. PubMed ID: 24187841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin.
    Iwai S; Okazaki M; Kiuchi Y; Oguchi K
    Thromb Res; 1999 Dec; 96(6):421-6. PubMed ID: 10632464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hypofibrinogenemia with batroxobin on rat Masugi nephritis.
    Tomita K; Muso E; Tamura T; Kawai C
    Jpn Circ J; 1982 Jun; 46(6):577-82. PubMed ID: 7045444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma levels and urinary excretion of batroxobin and its defibrinogenating effects in various animal species.
    Sugai K; Imamura Y; Mihashi S; Ohba M; Kunikane K; Mori N; Baba S
    J Toxicol Sci; 1986 May; 11(2):135-43. PubMed ID: 3522924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin: a solution to some problems of extracorporeal circulation. Experiments in greyhounds.
    Longmore DB; Bennett G; Gueirrara D; Smith M; Bunting S; Moncada S; Reed P; Read NG; Vane JR
    Lancet; 1979 May; 1(8124):1002-5. PubMed ID: 86720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defibrinogenation as an alternative to heparinization in prolonged extracorporeal circulation.
    Roy J; Guidoin R; Martin L; Lephat H; Blais P; Marois M; Gagnon D; Awad J
    Res Exp Med (Berl); 1980; 176(3):219-34. PubMed ID: 6988926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposable filters for microaggregate removal from extracorporeal circulation.
    Guidoin R; Laperche Y; Martin L; Awad J; Winchester J
    J Thorac Cardiovasc Surg; 1976 Apr; 71(4):502-16. PubMed ID: 131221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of anticoagulation methods available for extracorporeal circulation in the dog].
    Legendre L; Guidoin R; Martin L; Blais P; Marois M; Roy J; Awad J
    Union Med Can; 1980 Mar; 109(3):387-96. PubMed ID: 6990575
    [No Abstract]   [Full Text] [Related]  

  • 19. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
    Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
    Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.